Q2 2021 Holdings
Filed 2021-08-16 | 38 holdings | $47.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $33.0M | 987,406 | 70.1% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $8.9M | 108,000 | 19.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.1M | 175,000 | 6.5% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $1.9M | 329,134 | 4.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $36.9K | 11,728,033 | 0.1% |
| Celldex Therapeutics Inc New(CLDX)Put | COM NEW | 15117B202 | $16.7K | 500,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $10.1K | 160,500 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $8.9K | 843,122 | 0.0% |
| Verastem Inc | COM | 92337C104 | $8.2K | 2,018,433 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $7.9K | 1,250,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.8K | 417,409 | 0.0% |
| Seelos Therapeutics Inc | COM | 81577F109 | $7.6K | 2,860,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $7.4K | 353,398 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $6.7K | 232,896 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $6.4K | 1,316,268 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $6.3K | 604,074 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $6.2K | 478,401 | 0.0% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $5.9K | 277,777 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $5.6K | 562,500 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $4.4K | 427,060 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $4.4K | 214,254 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $4.3K | 1,024,668 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $4.1K | 509,164 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.0K | 392,500 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $3.9K | 149,495 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $3.8K | 561,011 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.5K | 206,126 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.3K | 369,863 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $3.3K | 150,000 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $3.0K | 685,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $2.9K | 50,945 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $2.5K | 162,245 | 0.0% |
| Catabasis Pharmaceuticals in(CATBEUR) | COM NEW | 14875P206 | $2.5K | 1,173,674 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $1.5K | 60,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $1.4K | 10,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.3K | 301,904 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $491 | 2,315 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $236 | 90,832 | 0.0% |